Jeffrey Paley - Director, Avenue Therapeutics, Inc

As of December 12, 2018


Jeffrey Paley Net Worth

  • Net worth is estimated to be at least $1.01M
  • Owns at least 79,663 units of Avenue Therapeutics, Inc stock

Jeffrey Paley Trading

  • Largest purchase of shares was 15,000 units , worth over $78.55K on December 12, 2018
  • In total has made about 2 transactions over 4 months
  • Usually trades in December and August, with the busiest year in 2018
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Jeffrey Paley Mailing Address

  • Mailing address is C/o Retrophin Inc., 777 Third Avenue 22nd Floor New York NY 10017 NY

Avenue Therapeutics, Inc Executive Compensation

Name
Year
Salary
Bonus
Stock Awards
Other Earnings Plans or Compensations
Other Compensation
Total
Lucy Lu 2019 $419,055 - - $209,528 $11,200 $639,783
Lucy Lu 2018 $406,850 - $865,000 $315,309 $7,474 $1,594,633
Joseph Vazzano 2019 $198,113 - - $50,000 $10,666 $258,779
Joseph Vazzano 2018 $175,100 - $103,800 $67,851 $7,777 $354,528
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1644963/000110465920052889/tm2016453-1_def14a.htm

Avenue Therapeutics, Inc Insider Trading

  • The most recent transaction was 7,160 units sold on September 15, 2021 by Joseph Vazzano worth over $11.6K
  • In the last 4 years, insiders at Avenue Therapeutics, Inc sold an estimated value of $84.38K and bought an estimated value of $662.86K
  • The most active traders are Neil Herskowitz, Director,  Joseph Vazzano, Chief Financial Officer,  and Lu Lu, President
  • Insider trading is most common in August, with the busiest year in 2018

AVENUE THERAPEUTICS, INC. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1